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The microRNA miR-181c controls
microglia-mediated neuronal apoptosis by
suppressing tumor necrosis factor
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Abstract
Background: Post-ischemic microglial activation may contribute to neuronal damage through the release of large
amounts of pro-inflammatory cytokines and neurotoxic factors. The involvement of microRNAs (miRNAs) in the
pathogenesis of disorders related to the brain and central nervous system has been previously studied, but it
remains unknown whether the production of pro-inflammatory cytokines is regulated by miRNAs.
Methods: BV-2 and primary rat microglial cells were activated by exposure to oxygen-glucose deprivation (OGD).
Global cerebral ischemia was induced using the four-vessel occlusion (4-VO) model in rats. Induction of pro-
inflammatory and neurotoxic factors, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and nitric oxide (NO),
were assessed by ELISA, immunofluorescence, and the Griess assay, respectively. The miRNA expression profiles of
OGD-activated BV-2 cells were subsequently compared with the profiles of resting cells in a miRNA microarray.
BV-2 and primary rat microglial cells were transfected with miR-181c to evaluate its effects on TNF-α production
after OGD. In addition, a luciferase reporter assay was conducted to confirm whether TNF-α is a direct target
of miR-181c.
Results: OGD induced BV-2 microglial activation in vitro, as indicated by the overproduction of TNF-α, IL-1β, and
NO. Global cerebral ischemia/reperfusion injury induced microglial activation and the release of pro-inflammatory
cytokines in the hippocampus. OGD also downregulated miR-181c expression and upregulated TNF-α expression.
Overproduction of TNF-α after OGD-induced microglial activation provoked neuronal apoptosis, whereas the
ectopic expression of miR-181c partially protected neurons from cell death caused by OGD-activated microglia.
RNAinterference-mediated knockdown of TNF-α phenocopied the effect of miR-181c-mediated neuronal protection,
whereas overexpression of TNF-α blocked the miR-181c-dependent suppression of apoptosis. Further studies
showed that miR-181c could directly target the 30-untranslated region of TNF-α mRNA, suppressing its mRNA and
protein expression.
Conclusions: Our data suggest a potential role for miR-181c in the regulation of TNF-α expression after ischemia/
hypoxia and microglia-mediated neuronal injury.
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Background
Microglia are the resident innate immune cells of the CNS.
Microglia display a quiescent phenotype in the healthy
brain, but they become highly activated after brain insult,
when they produce reactive oxygen and nitrogen species
and pro-inflammatory cytokines [1-5]. Therefore, micro-
glial cells play important roles in the surveillance of and re-
sponse to pathological insults [6]. The available evidence
has indicated that microglial activation results in the over-
production of pro-inflammatory cytokines, which may
contribute to the development and progression of neuro-
degenerative disorders [7]. For example, activated microglia
and their secreted factors, such as tumor necrosis factor
(TNF)-α, are key mediators of neuroinflammation, which
have been shown to correlate with neurodegenerative dis-
eases such as Alzheimer’s disease [8,9], Parkinson’s disease
[10,11] and HIV-associated dementia [12,13]. In addition,
activated microglia, by releasing pro-inflammatory cyto-
kines, participate in the inflammatory response associated
with cerebral ischemia[1]. Overproduction of inflammatory
factors from ischemia-activated microglia is thought to me-
diate post-ischemic neuronal damage [14].
MicroRNAs (miRNAs) are a class of small non-coding
RNA molecules, 22to 25 nucleotides in length, that func-
tion in the post-transcriptional regulation of gene ex-
pression. miRNAs bind partly complementary sequences
in mRNAs, targeting them for degradation and/or inhi-
biting their translation, and thereby downregulating the
expression of the targeted proteins [15]. Dysregulation
of miRNAs has been shown to contribute to many types
of human diseases, including neuronaldisorders [16-18].
However, there are almost no data on the miRNA ex-
pression profiles of microglial cells exposed to hypoxia.
Although microglial activation is considered to be the
hallmark of neuroinflammation [7], it remains unknown
whether expression of pro-inflammatory cytokines dur-
ing microglial activation is regulated by miRNAs.
In this study, we used oxygen-glucose deprivation
(OGD)-activated microglial cells, which are characterized
by the overproduction of pro-inflammatory and neurotoxic
factors. Wefound that OGD downregulated miR-181c ex-
pression but upregulated TNF-α expression. The overpro-
duction of TNF-α that followed OGD-induced microglial
activation induced neuronal apoptosis, whereas ectopic ex-
pression of miR-181c partially protected neurons from cell
death caused by OGD-activated microglia. Therefore, our
data suggest an important role for miR-181c in the regula-




All cell culture products were purchased from Gibco
(Carlsbad, CA, USA). The following antibodies were
used: anti-CD11b (Millipore, Bedford, MA, USA), anti-
TNF-α, anti-inducible nitric oxide synthase (iNOS;
Abcam, Cambridge, MA, USA), anti-interleukin (IL)-1β
(Santa Cruz Biotechnology, CA, USA), and anti-
glyceraldehyde 3-phosphate dehydrogenase (GAPDH;
Cell Signaling Technology, Beverly, MA, USA). Recom-
binant soluble (s)TNF was purchased from Peprotech
(Rocky Hill, NJ, USA).
Microglial cell culture
The Shanghai Medical Experimental Animal Care Com-
mittee approved the protocol for this study, and all ani-
mal experiments were conducted in accordance with the
National Institutes of HealthGuidelines for the Care and
Use of Laboratory Animals.
Primary hippocampal microglial cells were isolated
from glial cultures prepared from newborn (less than
24 hours old) Sprague–Dawley (SD) rats(Laboratory Ani-
mal Center, Shanghai Medical College, Fudan University,
Shanghai, China). Glial cells were cultured in 75 cm2
flasks for 14 days in DMEM/F12 (Gibco BRL, Grand
Island, NY, USA) supplemented with 10% FCS(Hyclone,
Logan, UT, USA), 100 U/ml penicillin and 100 mg/ml
streptomycin. Microglia were isolated from primary
mixed glial cell cultures on day 10 by shaking the flasks
overnight at 300 rpm on a rotary shaker at 37°C. The
purity of the microglial cultures was assessed as over
90%, using a CD11b antibody. Cells were cultured for 2
daysbefore treatment.
The BV-2 murine microglial cell line and rat primary-
cultured microglial cells were maintained in DMEM
supplemented with 10% FCS.
Oxygen-glucose deprivation and preparation of microglial
conditioned medium
OGD was performed with the microglial cells as
reported previously [19], with minor modifications.
Briefly, microglial cells were initially maintainedin
serum/glucose-free DMEM in an anoxic (95% N2 and
5% CO2) environment at 37°C for 1 hour. The cells were
then transferred to a normoxic incubator (95% air, 5%
CO2) and maintained in serum-free defined medium.At
48 hours after OGD, the medium conditioned with the
microglial cells was harvested. This fresh, conditioned
medium was cleared by centrifugation and diluted 1:1
with serum-free defined medium, then used to treat the
neurons For all experiments, conditioned media from
the indicated microglia were collected simultaneously
and used in parallel.
Four-vessel occlusion
Transient forebrain ischemia was induced by four-vessel
occlusion (4-VO) as described by Pulsinelli [19]. Briefly,
male Wistar rats weighing 260 to 320 g were anesthetized
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with 4% (w/v) chloral hydrate 400 mg/kg administered
intraperitoneally. The bilateral vertebral arteries were per-
manently electrocauterized and the bilateral common ca-
rotid arteries (CCAs) were freed,then atraumatic clasps
were placed around the CCAs without interrupting the ar-
terial blood flow. The rats were allowed to recover for
24 hours after the surgical incisions were closed. On the
next day, the rats were anesthetized, and forebrain ischemia
was induced by tightening the clasps for 20 minutes. The
clasps were then removed for reperfusion. In sham-
operated groups, the same procedure was performed with-
out the 4-VO procedure.
Tissue preparation
At 3 daysafter ischemia induction, animals were deeply
anesthetized, then killed by perfusion with saline, fol-
lowed by 4% paraformaldehyde in 0.1 mol/L phosphate
buffer (pH 7.4). Brains were removed and post-fixed for
4 hours in the same fixative, then embedded in optimum
cutting temperature compound, and stored at −70°C.
Serial sections (20 μm in thickness) were cut on a cryo-
stat. Only those regions that contained the same coronal
plane as the hippocampus were evaluated.
Immunofluorescence
Sections were incubated with primary antibodies against
anti-CD11b (mouse monoclonal antibody; dilution
1:300) and anti-iNOS (rabbit monoclonal; dilution
1:100) overnight at 4°C. After thorough washing, the
cells were incubated with fluorescein isothiocyanate-
conjugated anti-rabbit IgG (goat, 1:500 dilution; Santa
Cruz Biotechnology) or with DyLight 649-conjugated
anti-mouse IgG (goat, 1:500 dilution; Santa Cruz Bio-
technology) for 1.5 hours at room temperature. Finally,
the cells were washed and mounted with mounting
medium containing DAPI (Vector Laboratories). A nega-
tive control, in which the primary antibody was omitted,
was used to test for the specificity of the antibody being
used. The images were captured using a conventional
fluorescence microscope (Leica, Heerbrugg, Switzerland).
Primary culturing of hippocampal neurons
Primary hippocampal neuronal cultures were prepared as
described previously [20]. Briefly, the hippocampi of new-
born (< 24 hours old) SD rats were dissected and incubated
in Hank’s balanced salt solution without Ca2+ or Mg2+. The
tissues were subsequently dissociated using 0.125% trypsin
(Gibco BRL, Grand Island, NY, USA) by digesting for
15 minutes at 37°C followed by gentle trituration through a
flame-polished Pasteur pipette. The dissociated cells were
seeded onto glass coverslips coated with poly-L-lysine (mo-
lecular weight 30,000 to 70,000, 0.1 mg/ml; Sigma-Aldrich,
St. Louis, MO, USA) or into 24-well plates at a density of
1× 106 cells/ml. The cells were cultured in serum-free
medium (Neurobasal-A; Gibco BRL,Gaithersburg, MD,
USA) and supplemented with 2% B27 (Gibco BRL), 10 μL/
ml penicillin-streptomycin and 2 mmol/l glutamine (Solar-
bio). The cells were maintained by changing the medium
every 2–3 days and incubating at 37.8°C in a humidified at-
mosphere containing 5% CO2. The purity of the neuronal
cultures was determined by immunocytochemical staining
using an antibody against neurofilament proteins (a
neuron-specific marker). and more than 90% of the cells
were found to be neurons.
Hoechst staining assay for apoptosis
For Hoechst 33342 staining, neurons were fixed in 4%
paraformaldehyde and incubated for 10 minutes at room
temperature with 5 μg/ml Hoechst 33342 (Sigma Chem-
ical Co, St. Louis, MO). Cells were analyzed using a con-
ventional fluorescence microscope (Leica), and the
neurons with clearly condensed and segmented chroma-
tin were counted as apoptotic. For all of the groups, 300
cells (including the normal and apoptotic cells) were
counted manner using fluorescence microscopy by a re-
searcher blinded to the treatment given. Three inde-
pendent experiments were performed for each group.
RNA isolation, microarrays, and real-timePCR
Total RNA was extracted from the BV-2 or primary cul-
tured cells (both with and without OGD treatment) using
TRIzol reagent (Invitrogen, San Diego, CA, USA) in ac-
cordance with the manufacturer’s instructions. Small RNAs
were isolated using a commercial kit (miRNA Isolation Kit;
Ambion, Inc., Austin, TX, USA). Array experiments were
performed by a company (CapitalBio Corp., Beijing, China)
as described on the company’s website (http://www.capital-
bio.com) and in previous reports [21,22], using an miRNA
array (GeneChip miRNA Array; Affymetrix Inc., Santa
Clara, CA, USA),which is composed of 6,703 probe sets
from the miRNAs registered in the Sanger miRBase
miRNA database (version 11; http://microrna.sanger.ac.uk;
accessed 15 April 15 2008). Semi-quantitative real-time
PCR, using SYBR Green I, was conducted to compare the
relative expression levels of specific mRNAs, as described
previously [23]. TaqMan miRNA assays (Applied Biosys-
tems Inc., Carlsbad, CA, USA) were used to quantify ma-
ture miRNA expression levels,in accordance with the
manufacturer’s protocol. For each of the selected miRNAs,
real-time PCR measurements were performed to obtain a
mean CT value for each sample. The CT valuesof the differ-
ent samples were compared using the 2-ΔΔCT method [24],
and U6 expression levels were used as an internal
reference.
Western blotting analysis
Western blotting was performed as described previously
[25]. Briefly, total protein was extracted from cultured
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cells and quantified using a commercial bicinchoninic
acid (BCA) kit(BCA Protein Assay Kit; Pierce Biotech-
nology Inc., Rockford, IL, USA) with BSA as the stand-
ard. Equal amounts of protein from different cells were
separated by 10% SDS-PAGE and transferred to a nitro-
cellulose membrane (Bio-Rad, Hercules, CA, USA). The
membrane was blocked with 5% non-fat milk, and incu-
bated with primary antibodies against TNF-α (rabbit
polyclonal; 1:500 dilution) and GAPDH (rabbit mono-
clonal; 1:3000 dilution). The blots were then incubated
for 2 hours at room temperature with horseradish
peroxidase-conjugated secondary antibodies (goat;
1:3000 dilution) in blocking buffer and appropriate sec-
ondary antibodies. Target proteins were detected using
an enhanced chemiluminescence kit (Amersham Phar-
macia Biotech, Uppsala, Sweden).
Measurement of cytokine release by enzyme-linked
immunosorbent assay
To detect the levels of pro-inflammatory factors in the
hippocampus, rats were killed at defined time points.
Brain homogenates were obtained from the hippocampi
,and separated by centrifugation at 14,000 g for 5 minutes
at 4°C to remove cellular debris. The supernatant was
stored at −80°C until use. To detect cytokine secretion
in microglial supernatants in response to OGD, cells
were plated intosix-well plates and exposed to OGD or
normoxic conditions, as described above. After 48 hours,
the media were collected and stored at −80°C until use.
The concentrations of IL-1β and TNF-α in the stored
media were measured using a sandwich ELISA kit (Duo-
Set; R&D Systems, Minneapolis, MN, USA).
Nitric oxide production assay
Nitric oxide (NO) levels were determined by measuring
the levels of the stable metabolite nitrite in the culture
medium, as described previously [26]. Briefly, BV-2 or
primary rat microglial cells in 24-well plates (2 × 105
cells in 500 ml/well) were exposed to OGD. Sample ali-
quots (100 ml) were mixed with 100 ml Griess reagent
and incubated at 25°C for 10 minutes. Absorbance at
550 nm was measured on a microplate reader.
Oligonucleotide transfection
The miRNA duplexes corresponding to miR-181c were
designed as described previously [27]. The control RNA
duplexes (referred to as NC for ‘negative control’)
for the miRNA mimics and the small interfering RNAs
(siRNAs) were not homologous to any human gene
sequences. The siRNAs were synthesized by targeting
mouse TNF-α (GenBank accessnumber NM_013693)
transcripts. The sequences of the RNA oligoribonucleo-
tides (Genepharma, Shanghai, China)are shown in
Table 1. Oligonucleotide transfection was performed
with commercialreagents (Lipofectamine 2000; Invitro-
gen Corp.). Each transfection used 50 nmol/L of RNA
duplexes.
Vector construction and luciferase reporter assays
To generate the miR-181c expression vector, the miR-
181c gene was amplified from mouse genomic DNA and
cloned into the pcDNA3.0 vector (Invitrogen Corp.).
The open reading frame of the mouse TNF-α gene was
amplified and cloned into the pcDNA3.0 vector. The
luciferase complexes were constructed by ligating oligo-
nucleotides containing the wild-type or mutated putative
target site of the mouse TNF-α 30-untranslated region
(UTR) into the multi-cloning site of the p-MIR lucifer-
ase reporter vector (Ambion Inc., Austin, TX, USA).
HEK293 or BV-2 cells were cotransfected with 80 ng of
the luciferase reporter plasmid, 40 ng of the pRL-TK-
Renilla-luciferase plasmid (Promega Corp., Madison, WI,
USA), and the indicated RNAs (final concentration 20
nmol/l). At 24 hours after the transfection, the firefly
and Renilla luciferase activities were measured (Dual-
Luciferase Reporter Assay; Promega Corp.). Each trans-
fection was repeated twice in triplicate.
Statistical analyses
All data are expressed as the mean ± SE of at least
three independent experiments performed in triplicate.
Statistical analyses were performed using ANOVA
models and Student’s t-tests. P < 0.05 were considered
significant.
Results
Hypoxia/ischemia induces microglial activation and the
release of pro-inflammatory cytokines and
neurotoxic factors
Microglia activated by ischemic conditions have been
shown to release pro-inflammatory and neurotoxic
factors, such as IL-1, TNF-α and NO, which may be
responsible for severe brain-tissue damage [2,3].
Therefore, real-time PCR and ELISA were used to as-
sess the induction of IL-1β and TNF-α in BV-2 micro-
glia exposed to OGD. BV-2 cells were activated after
Table 1 The sequences of the RNA oligoribonucleotides
used for transfection
Name Direction Sequence (50!30)




TNF-α siRNA Forward UGAGGUCAAUCUGCCCAAGUACUUA
Reverse UAAGUACUUGGGCAGAUUGACCUCA
miR, microRNA; NC, negative control; TNF-α siRNA, tumor necrosis factor-α
small interfering RNA.
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OGD (Figure 1), characterized by the overexpression
of IL-1β and TNF-α mRNA as detected by real-time
PCR, and by the secretion of the cytokines IL-1β and
TNF-α as detected by ELISA. In addition, OGD caused
expression of iNOSand mRNA, and overproduction of
the neurotoxic factor, NO (Figure 1C,F).
We further confirmed these effects in a rat model. We
induced 20 minutes of global cerebral ischemia by 4-VO
in rats, and studied the microglial activation and release
of pro-inflammatory cytokines in the hippocampus.
We evaluated microglial activation 3 days afterI/R. We
detected increased levels of IL-1β and TNF-α in the
hippocampus by ELISA (Figure 1G). After 3 days of I/R,
the number of microglia was markedly increased in
the hippocampal CA1 region. By contrast, only a few
scattered ramified microglia (resting microglia) were
seen in sham-operated rats (Figure 1H). In addition, im-
munofluorescence showed that transient global cerebral
I/R significantly increased expression of iNOS in the
hippocampus (Figure 1H). These results indicate that
hypoxia/ischemia induces microglial activation and the
release of pro-inflammatory cytokines and neurotoxic
factors.
Oxygen-glucose deprivation upregulates tumor necrosis
factor-α expression and downregulates microRNA
(miR)-181c expression in BV-2 cells
We further evaluated the miRNA expression profiles of the
OGD-activated BV-2 cells compared with the resting cells
by miRNA microarray. The thresholdfoldchange value to
screen for upregulated and downregulated miRNAs was
≥1.5. In total, 26 miRNAs that exhibited significantly
altered expression levels between the hypoxic and nor-
moxic conditions were identified. Of these 26 miRNAs, 7
were upregulated and 19 were downregulated. miR-181c
exhibited the highest degree of downregulation in the acti-
vated microglia (Figure 2A). Subsequent database searches
of both the TargetScan (http://www.targetscan.org) and
Sanger (http://microrna.sanger.ac.uk) sitesshowed that
TNF-α mRNAs have conserved miR-181c recognition sites
in their 30-UTRs (Figure 2B). It is generally accepted that




Figure 1 Hypoxia/ischemia induces microglial activation and the release of pro-inflammatory cytokines and neurotoxic factors. (A-C)
BV-2 cells were exposed to oxygen-glucose deprivation (OGD), and the mRNA levels of the pro-inflammatory cytokines (A)tumor necrosis factor
(TNF)-α, (B) interleukin (IL)-1β and (C)inducible nitric oxide synthase (iNOS) were evaluated using real-time PCR at 3 hoursafter OGD treatment.
(D-E) The release of(D) TNF-α (E) and IL-1β into the medium of BV-2 cells was measured by ELISA at 48 hours after OGD. (F) The release of NO
into the medium of BV-2 cells was measured by the Griess assay. Results are presented as the mean± SE from three independent experiments.
(G) Brain homogenates were obtained from the hippocampus 3 daysafter transient global cerebral ischemia/reperfusion (I/R) injury. The
supernatant concentrations of IL-1β and TNF-α were tested by ELISA. (H) Sections from rat brain taken 3 daysafter I/R injury were incubated with
primary antibodies against CD11b and iNOS. Representative immunoreactivities in the hippocampal CA1 region are shown. Photomicrographs are
shown at ×400 magnification. ‘Ctrl’ (control) represents the microglial cells that were not subjected to OGD treatment. *P< 0.05.
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expression of their downstream target genes. To confirm
this inverse correlation between the expression of miR-
181c and TNF-α found in this study, we measured the
mRNA expression levels of TNF-α at different time points
after OGD treatment. TNF-α exhibited increased levels of
mRNA expression, whereas expression of miR-181c was
significantly decreased after treatment (Figure 2C). These
results confirmed an inverse correlation between expres-
sion of miR-181c and TNF-α during hypoxia-induced
microglial activation.
Tumor necrosis factor-α is a direct target of microRNA
(miR)-181c
As detailed above, OGD upregulated TNF-α and down-
regulated miR-181c expression in microglial cells. We
hypothesized that increased TNF-α production might re-
sult from the downregulation of miR-181c. To address
this hypothesis, a dual-luciferase reporter system was
used (Figure 3A). Coexpression of miR-181c significantly
suppressed the firefly luciferase reporter activity of the
wild-type 30-UTR but not of the mutant 30-UTR in both
HEK193T (Figure 3B) and BV-2 cells (Figure 3C), indi-
cating that miR-181c suppresses TNF-α expression
through miRNA binding sequences in its 30-UTR. Fi-
nally, BV-2 cells were transfected with the NC or miR-
181c duplexes. miR-181c was capable of significantly
suppressing the mRNA and protein expression of
TNF-α (Figure 3D). Taken together, this result suggests
that miR-181c suppresses TNF-α expression by binding
to the 30-UTR, and that TNF-α is a direct target of
miR-181c.
Ectopic expression of microRNA (miR)-181c attenuates
oxygen-glucose deprivation-activated BV2-induced
neuronal apoptosis
TNF-α is a key pro-inflammatory cytokine, and
increased levels of this cytokine have been associated
with the pathology of a variety of neurological, neurode-
generative, and neurotoxic conditions [28]. TNF-α can
activate receptor-mediated pro-apoptotic pathways
within the neuron. TNF-α can also stimulate microglial
activation in the form of iNOS induction, which leads to
the production of NO, a neurotoxic factor associated
with brain injury [29]. Therefore, we transfected micro-
glial cells with NC or miR-181c mimics and treated the
microglial cells with OGD. Evaluation of the harvested
microglia-conditioned mediumshowed that the miR-
181c-transfected cells secreted less TNF-α after OGD
(Figure 4A). In addition, the miR-181c-transfected
cells exhibited decreased iNOS expression and NO
Figure 2 Oxygen-glucose deprivation (OGD) upregulates tumor necrosis factor (TNF)-α expression and downregulates microRNA
(miR)-181c expression in BV-2 cells. (A) BV-2 cells were exposed to OGD for 3 hours. The miRNA was isolated, and the expression profiles of
OGD-activated BV-2 cells were compared with those of resting cells. A heat map of the 26 differentially expressed miRNAs (9 upregulated and
17 downregulated) is shown. (B) Alignment of the predicted miRNA binding sites in the 30-UTR of the TNF-α mRNA. (C) Relative expression levels
of BV-2 TNF-α mRNA and miR-181c at different time points after OGD treatment. Control cells were not subjected to OGD (0 hours). The results
are presented as the mean± SE from three independent experiments. ‘Ctrl’ (control) represents the control microglial cells that were not
subjected to OGD treatment.
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production (Figure 4B). To confirm whether the ectopic
miR-181c expression was able to attenuate activated
microglia-induced neuronal death, neurons were
exposed to cell-free conditioned medium collected from
microglia with or without the ectopic expression of miR-
181c. The ectopic expression of miR-181c significantly
reduced the neuronal apoptosis induced by OGD-
activated microglia (Figure 4C,D), suggesting that ec-
topic expression of miR-181c attenuates OGD-activated
BV2-induced neuronal apoptosis.
microRNA (miR)-181c controls microglia-mediated
neuronal apoptosis and is dependent on tumor
necrosis factor-α
To clarify the role of microglia-derived TNF-α in miR-
181c-mediated neuronal apoptosis, we first tested the
capacity of TNF-α to trigger death in cultured neurons.
We found that addition of soluble (s)TNF-α to the
neuron culture triggered apoptosis in a dose-dependent
manner (Figure 5A). Furthermore, addition of sTNF-α
significantly abrogated miR-181c-mediated neuronal sur-
vival (Figure 5B). Next, the effects of TNF-α silencing on
neuronal apoptosis were determined. We found that
silencing of TNF-α in the microglia-conditioned media
significantly decreased both TNF-α production
(Figure 5C) and microglia-mediated neuronal apoptosis
(Figure 5D), which was similar to the phenotype induced
by miR-181c. By contrast, the ectopic expression of
TNF-α using a TNF-α expression vector that encoded
the entire coding sequence of TNF but lacked its 30-
UTR expression significantly abrogated miR-181c-
induced neuronal survival (Figure 5E,F), indicating that
TNF-α is a functional target for miR-181c.
microRNA (miR)-181c controls tumor necrosis factor-α
production in primary rat microglial cells
To confirm the observations from the primary rat micro-
glia, primary-culturenewborn rat microglial cells were
used. As seenwith the BV-2 cells, miR-181c transfection
significantly suppressed basal TNF-α mRNA and protein
expression levels (Figure 6A,B). In addition, OGD led to
overproduction of secreted TNF-α in the primary rat
microglia, whereas ectopic expression of miR-181c sig-
nificantly reduced TNF-α production (Figure 6C). This
system was also used to confirm that ectopic expression




Figure 3 tumor necrosis factor-α is a direct target of microRNA (miR)-181c. (A) A mouse TNF-α 30-UTR fragment containing wild-type or
mutated miR-181c-binding sites was cloned downstream of the luciferase reporter gene. Mutations were generated in the TNF-α 30-UTR
sequences complementary to the seed region of miR-181c, as indicated. (B-C) Luciferase activity assays using reporters with wild-type or mutant
mouse TNF-α 30-UTRs were performed after co-transfection with miR-181c mimics or NC in HEK293 (B) or BV-2 (C) cells. The luciferase activity of
the NC transfection in each experiment was used to normalize the data; the luciferase activity of the NC transfection was set to 1. (D) BV-2 cells
were transfected with miR-181c mimics or NC. After 48 hours, cells were harvested, and the Expression levels of TNF-α mRNA and protein were
evaluated by real-time PCR and western blotting. The results are presented as the mean± SE from three independent experiments. Ctrl represents
the control microglial cells that were not subjected to OGD treatment; NC represents the negative control for the miR-181c mimics. *P < 0.05. NS,
not significant.
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activated primary rat microglia (Figure 6D). Finally, as
seen with the BV-2 cells, we found that miR-181c inhib-
ited OGD-induced iNOS expression and NO production
in primary rat microglia (Figure 6E,F). Taken together,
the results indicate that miR-181c controls microglia-
mediated neuronal apoptosis by suppressing TNF-α pro-
duction (Figure 7).
Discussion
To our knowledge, this study is the first to report the
miRNA expression profile of microglial cells exposed to is-
chemia, although it is already becoming clear that miRNA-
dependent post-transcriptional gene regulation plays pivotal
roles at all stages of neural development [30]. In addition,
for the first time, we have also identified in microglia a
microRNA, miR-181c, whichcan directly regulate TNF-α
production post-transcription.
Inflammation is an underlying component of a diverse
range of neurodegenerative diseases and their associated
neuropathologies. Increasing evidence suggests that micro-
glia are a key causative factor in this process [7,31]. Acti-
vated microglia serve initially to phagocytose necrotic
debris, which allows for the eventual healing of the injured
brain. However, under pathological conditions, activated
microglia can induce significant and strongly detrimental
neurotoxic effects through excess production of a large
array of cytotoxic factors, such as IL-1β, NO, reactive oxy-
gen species (ROS), and TNF-α [1,32]. In our study, we
found that OGD upregulated IL-1β, TNF-α, and iNOS.
However, although microglial activation is considered to be
a hallmark of neuroinflammation, whether the expression
of pro-inflammatory cytokines is regulated by miRNAs dur-
ing microglial activation has not been previously deter-
mined. Therefore, after identifying the miRNA profile of
ischemia-activated microglia, we investigated the correl-
ation between altered miRNA expression and pro-
inflammatory cytokines.
TNF-α is a key pro-inflammatory cytokine that has been
reported to play an important role in the events that follow
ischemia [33]. Increased levels of TNF-α have been asso-
ciated with the pathological effects of a variety of infectious,
neurological, neurodegenerative, and neurotoxic conditions
[33]. We analyzed the predicted TNF-α-regulating miR-
NAs that were downregulated in activated microglial
cells, and found that TNF-α might be regulated by miR-
181c. To better understand this regulatory relationship,
the capacity of miR-181c to directly regulate TNF-α ex-




Figure 4 Ectopic expression of microRNA (miR)-181c attenuates oxygen-glucose deprivation-activated BV2-induced neuronal
apoptosis. (A-B) BV-2 cells were transfected with miR-181c mimics or NC 24 hoursbefore activation by OGD. After 48 hours, the production
levels of TNF-α (A) and NO (B, top) were determined by ELISA and the Griess assay, respectively. The cells were harvested at 48 hours after
OGD, and iNOS protein expression was evaluated by western blotting (B, lower). (C-D) BV-2 cells were transfected with miR-181c mimics or NC
24 hoursbefore activation by OGD. After 48 hours, the conditioned media were harvested. Cultured neurons were grown in the
microglia-conditioned medium (MCM) and then analyzed for apoptosis using Hoechst 33342 staining. The percentage of apoptotic cells in
the total neuronal population was calculated (C). Representative photographs are shown in (D). The results are presented as the mean± SE from
three independent experiments. NC represents thenegative control for the miR-181c mimics. *P < 0.05.
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determine whether the dysregulated miRNAs were
functional, we confirmed that ectopic expression of
miR-181c resulted in decreased release of TNF-α from
the microglial cells and decreased neuronal apoptosis.
Silencing TNF-α also produced a significant decrease in
neuronal apoptosis in microglia-conditioned media,
which was similar to the phenotype induced by miR-
181c. Additionally, ectopic TNF-α expression signifi-
cantly abrogated the neuronal survivalinducec by miR-
181c. All these results suggest that miRNAs represent en-
dogenous functional microglial moleculesthat respond to
ischemia and produce a neurotoxic phenotype in micro-
glia. Taken together, the results from our study suggest
that some miRNAs lie upstream of pro-inflammatory
cytokines or other inflammatory mediators. However, we
cannot exclude the possibility that some of the miRNAs
that were upregulated in the activated microglia play a
role because they may act upstream of several anti-
inflammatory genes.
An increasing body of evidence indicates that oxidative
stress resulting from excessive generation of ROS and
reactive nitrogen species (RNS) is a causal factor in vari-
ous neurodegenerative disorders [34]. The interaction
between NO and superoxide anion-forming toxic perox-
ynitritehas been proposed as being involved in neuronal
injury [35,36]. TNF-α can activate receptor-mediated
proapoptotic pathways within the neuron, and can fur-
ther stimulate the microglia through iNOS and cycloox-
ygenase 2 induction [28,29]. Therefore, inhibition of
TNF-α production is expected to be beneficial in
inflammation-related neurological disorders. In our
study, we found that OGD resulted in increased produc-
tion of NO, whereas ectopic expression of miR-181c




Figure 5 microRNA (miR)-181c controls microglia-mediated neuronal apoptosis dependent on tumor necrosis factor (TNF)-α. (A)
Neurons were treated with vehicle or soluble (s)TNF-α as indicated. After 48 hours, the percentage of apoptotic cells in the total neuronal
population was calculated. (B) BV-2 cells were transfected with negative control (NC) or miR-181c as indicated before being subjected to OGD.
After 48 hours, the conditioned medium (CM) was harvested. sTNF-α was added to the CM at the indicated concentration before cultured
neurons were grown in microglia-conditioned medium (MCM) for 48 hours, and neuronal apoptosis was detected using Hoechst 33342 staining.
(C-D) BV-2 cells were transfected with NC or small interfering TNF before they were subjected to OGD. (C) TNF-α protein expression levels were
determined by western blotting after 24 hours, and TNF-α release levels were determined by ELISA after 48 hours. (D) Cultured neurons were
then grown in the MCM for 48 hours, and neuronal apoptosis was detected using Hoechst 33342 staining. (E, F) BV-2 cells were transfected with
NC, miR-181c or TNF-α (open reading frame without the 30-untranslated region) expression vectors as indicated, before being subjected to
OGD. (E) TNF-α protein expression levels were determined by western blotting after 24 hours, and TNF-α release levels were determined by ELISA
after 48 hours. (F) Cultured neurons were then grown in MCM for 48 hours, and neuronal apoptosis was detected using Hoechst 33342 staining.
The results are presented as the mean± SE from three independent experiments.NC represents the negative control for the miR-181c mimics.
*P< 0.05. NS, not significant.
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Figure 6 microRNA (miR)-181c controls tumor necrosis factor-α production in primary rat microglial cells. (A-B) Primary rat microglia cells
were transfected with miR-181c mimics or NC. After 48 hours, cells were harvested, and the TNF-α mRNA (A) and protein (B) expression levels
were evaluated by real-time PCR and western blotting. (C-D) Primary rat microglial cells were transfected with miR-181c mimics or NC 24
hoursbefore activation by OGD. After 48 hours, the production of TNF-α was determined by ELISA (C). Cultured neurons were then grown in the
microglia-conditioned medium (MCM) for 48 hours, and neuronal apoptosis was detected using Hoechst 33342 staining (D). (E-F) Primary rat
microglia cells were transfected with miR-181c mimics or NC 24 hoursbefore activation by OGD. After 48 hours, the production of NO was
determined by the Griess assay (E). The cells were harvested, and iNOS protein expression was evaluated by western blotting (F). The results are
presented as the mean± SE from three independent experiments. Ctrl represents the microglial cells that were not treated with oligonucleotide
transfection; NC represents the negative control for the miR-181c mimics. *P< 0.05. NS, not significant.
Resting microglia















Figure 7 A schematic of the role for microRNA (miR)-181c-tumor necrosis factor (TNF)-α in microglia-mediated neuronal injury.
Hypoxia-ischemia resulted in microglia activation and miR-181c downregulation. Downregulation of miR-181c leads to increased TNF-α
production, as TNF-α is a direct target of miR-181c. TNF-α can activate receptor-mediated proapoptotic pathways within the neuron. TNF-α can
also stimulate microglia activation in the form of inducible nitric oxide synthase (iNOS) induction, which leads to production of nitric oxide (NO)
Finally, the interaction between NO and superoxide anion (O2−) forms toxic peroxynitrite (ONOO−), which also causes neuron damage.
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production of NO. Therefore, our study indicates an im-
portant role of miR-181c in TNF-α-mediated neurotox-
icity after ischemia (Figure 7).
Our study also demonstrates the importance of inves-
tigating the mechanisms underlying cytokine regulation
when studying the effect of cytokines on neuronal injury,
because this information may facilitate the development
of more effective therapeutic interventions. Previous
studies have shown enhancement of neuronal damage by
TNF-α in vivo in ischemia models. For example, intra-
cerebroventricular administration of TNF-α increased
the lesional area produced by focal ischemia, whereas in-
hibition of TNF-α activity by administration of soluble
TNF-α receptors or anti-TNF-α antibodies reduced the
ischemic damage [37]. Clinical studies on the effects
produced by modification of cytokines in CNS disease
are currently underway. At present, the main challenge
is to deliver sufficient levels of cytokines or their modi-
fiers to the ischemic or injured brain. miRNAs may rep-
resent a new drug target class. By taking advantage of
their small size and the current knowledge of miRNA
biogenesis, modified RNAs can be transiently delivered
as synthetic, pre-processed miRNAs or as anti-miRNA
oligonucleotides [38].
Delivering an miRNA that reduces the protein levels of
target genes linked to a particular disease by post-
transcriptional regulation or that targets a particular func-
tional miRNA linked to a particular disease represents new
therapeutic options. A recent study has shown that the
in vivo administration of miR-124 suppresses experimental
autoimmune encephalitisby affecting macrophages, sug-
gesting that miRNA delivery could be used to treat some
inflammatory diseases associated with microglial activation
[39]. A recent report also showed that another member of
the miR-181c family, miR-181a, could influence cerebral is-
chemia outcomes in vitro and in vivo by regulating GRP78
expression in astrocytes [40]. Collectively, all of these stud-
ies have indicated that manipulating miRNA levels could
be a potential treatment strategy for ischemic brain injury.
Conclusions
We identified a correlation between miRNA levels and
the expression of genes involved in pro-inflammatory
cytokine production. We also characterized one particu-
lar molecular series, the miR-181c-TNF-α pathway,
which is partially responsible for microglia-mediated
neuronal apoptosis. Our data suggest a potential role for
miR-181c in the regulation of TNF-α expression after is-
chemia/hypoxia and microglia-mediated neuronal injury.
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